TRIM28 and cancer: The average percentage of KAP1-positive cancer cells was 57.03% (range = 0%–94.0%) in serous carcinomas, 57.97% (range = 0%–90%) in endometrioid adenocarcinomas, 61.67% (range = 40.0%–82.0%) in clear cell adenocarcinomas, and 35% (range = 0%–60.0%) in mucinous carcinomas.